Rodney S. Markin, Director at Cardiff Oncology, Inc. (CRDF), bought 2,900 shares at $10.32 ($30K) on 2021-03-26, disclosed to the SEC on 2021-03-29.
Open-market purchase of $30k CRDF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |